Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Safety and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Administered With and Without an Adjuvant Patch in Healthy Adults

NCT00532792 is registered in ClinicalTrials.gov with Intercell USA, Inc. as lead sponsor.

NCT NCT00532792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00532792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Observer-Blind, Placebo-Controlled Study to Assess the Safety and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine Administered With and Without an Adjuvant Patch in Healthy Adults
Lead sponsor
Intercell USA, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2007
Completion date
June 30, 2008
Enrollment
501 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

pandemic influenza